BMRAライブシグナル | Getagraph.comで利益を最大化

売る 115066 min ago

@ $0.940

発行日: 10 2月 2024 @ 04:05

リターン: -37.22%

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:50):

Stats
本日の出来高	6.42M
平均出来高	70 559.00
時価総額	9.93M
EPS	$0 ( 2024-04-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.590
ATR14	$0.0130 (2.20%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Coste Catherine	Buy	75 000	Non-qualified stock option
2023-12-13	Moatazedi David	Buy	75 000	Non-qualified stock option
2023-12-13	Kenny John P.	Buy	75 000	Non-qualified stock option
2023-12-13	Emerson Jane	Buy	75 000	Non-qualified stock option
2023-12-13	Lu Gary	Buy	155 000	Non-qualified stock option

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 712 565 \| Sell: 242 000

ボリューム相関

長: -0.06 (neutral)

短: -0.68 (moderate negative)

Signal:(29.362) Neutral

Biomerica Inc 相関

10 最も正の相関
AVGR	0.967
ARVL	0.967
FCBC	0.962
USEG	0.96
ISUN	0.959
ATNF	0.958
CMBM	0.957
SEV	0.957
PMVP	0.957
CAAS	0.956

10 最も負の相関
MLAI	-0.976
TCMD	-0.974
OXUS	-0.973
TZPS	-0.971
IPAR	-0.969
CBRG	-0.966
BIOT	-0.966
ORIA	-0.964
TZPSU	-0.963
BIOS	-0.962

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Biomerica Inc 相関 - 通貨/商品

0.27
( neutral )

0.59
( weak )

0.00
( neutral )

-0.32
( neutral )

0.00
( neutral )

-0.50
( neutral )

Biomerica Inc 財務諸表

Annual	2023
収益:	$5.34M
総利益:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2023
収益:	$5.34M
総利益:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2022
収益:	$18.87M
総利益:	$2.98M (15.78 %)
EPS:	$-0.360

FY	2021
収益:	$7.20M
総利益:	$496 981 (6.90 %)
EPS:	$-0.540

Financial Reports:

No articles found.

Biomerica Inc

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.